Efficacy and safety of the combination of anlotinib and envafolimab in the treatment of unresectable or metastatic liposarcoma: findings from a single-center retrospective study

Efficacy and safety of the combination of anlotinib and envafolimab in the treatment of unresectable or metastatic liposarcoma: findings from a single-center retrospective study

ObjectiveTo evaluate the efficacy and safety of anlotinib combined with envafolimab in the treatment of unresectable or metastatic liposarcoma.MethodsThis single-center, retrospective study enrolled 15 patients with unresectable or metastatic liposarcoma, who were treated at the Retroperitoneal Tumo...

Full description

Saved in:
Bibliographic Details
Main Authors: Hongliang Liu, Qisheng Hao, Xi Wang, Mengxing Cheng, Fabo Qiu, Bin Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Oncology
Subjects:
liposarcoma
targeted therapy
immunotherapy
efficacy
safety
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1502945/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items